The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at least 25 U.S. states, according to reports.

Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...

Warning: COVID Vaccines Linked to Cancer Risks, Experts Say** In a shocking revelation that could alter the narrative surrounding COVID-19 vaccinations, a prominent molecular vi ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program.  | Bristol Myers ...

Tris Pharma, Inc. (Tris) has announced the promotion of Manesh Naidu, MBA, to chief commercial officer. Naidu previously ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Acepodia, a start-up developing cell therapies, is collaborating with Pfizer Ignite, which will offer research and development support for drug candidates targeting autoimmune diseases. Acepodia is ...